July 24, 2025 - 18:29

In a significant development, Yale New Haven Health has announced that it will cease providing medication for youth gender-affirming care services. This decision follows closely on the heels of a similar announcement from Connecticut Children's Medical Center, raising concerns about the future of healthcare options for transgender and non-binary youth in the region.
The discontinuation of these services has sparked a wave of reactions from advocacy groups and community members who emphasize the importance of accessible and affirming healthcare for young individuals navigating their gender identity. Many argue that gender-affirming care is crucial for the mental and emotional well-being of these youths, who often face significant challenges in their personal lives.
As healthcare providers reassess their policies and services, the implications of these changes will likely resonate throughout the community, prompting discussions about the availability of supportive care and the rights of transgender youth. The future of gender-affirming care in the area remains uncertain, as stakeholders seek to understand the full impact of these recent decisions.
May 9, 2026 - 22:43
College of Pharmacy & Health Sciences confers 206 degrees - NewsThe Campbell University College of Pharmacy & Health Sciences held its spring commencement ceremony to honor the achievements of the Class of 2026. A total of 206 degrees were conferred during the...
May 9, 2026 - 02:40
California Becomes First State to Offer Free Diapers for Every NewbornCalifornia is set to launch a first-of-its-kind program that will provide free diapers to every newborn in the state. The initiative, which makes California the first state in the country to offer...
May 8, 2026 - 11:45
Maryland ranked high among states for public health preparedness, but could be doing moreMaryland continues to rank among the top states in the nation for its ability to handle public health emergencies, according to a recent analysis by a national health policy organization. The state...
May 7, 2026 - 18:47
Healthy Returns: First Ozempic generics in Canada will be a test case for Novo NordiskThe arrival of the first generic versions of semaglutide in Canada is being watched closely as a potential turning point for Novo Nordisk`s dominance in the global weight-loss and diabetes market....